ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103044 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$47M
Latest Revenue (FY2022)
+12.7%
Revenue CAGR (3yr)
29.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $37M | $45M | $47M | +5.2% | +12.7% |
| Operating Expenses | $26M | $31M | $33M | +8.9% | +13.8% |
| Operating Margin | 30.6% | 31.8% | 29.4% | -7.6% | -2.1% |
| Net Income | $11M | $14M | $14M | -2.8% | +10.4% |
| Licensed Beds | 80 | 80 | 80 | +0.0% | +0.0% |
| Total Patient Days | 23,564 | 27,696 | 28,123 | +1.5% | +9.2% |
| Medicare Day % | 73% | 72% | 73% | +1.1% | +0.0% |
| Medicaid Day % | 0% | 0% | 0% | -38.4% | +7.9% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +27.1% ($37M → $47M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.7%
This Hospital
+7.6%
State Avg
Latest Margin
29.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | 28.7% |
| FY2024 (proj) | $57M | 28.1% |
| FY2025 (proj) | $63M | 27.5% |